Cash-strapped biotech signs deal with Chinese drugmaker BeiGene
January 03, 2020 at 14:11 PM EST
A small Cambridge biotech is getting a much-needed infusion of cash, signing what its CEO called a “transformative” collaboration deal with Chinese drugmaker BeiGene Ltd.
